Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →16
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,032
Total Claims
$5.5M
Drug Cost
781
Beneficiaries
$7,086
Cost/Patient
Risk Score Breakdown 16/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+503%
Cost per patient vs peers
$7,086 vs $1,174 avg
+577%
Brand preference vs peers
60.0% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Cost per patient is 503% above the specialty average. Extreme cost outliers may indicate prescribing of unnecessarily expensive brand-name drugs or inappropriate drug utilization.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Brand vs Generic
Brand: 5,014 claims · $5.0M
Generic: 3,344 claims · $74K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 539 | $720K |
| Dapagliflozin Propanediol | 357 | $392K |
| Insulin Aspart | 264 | $369K |
| Insulin Glargine,hum.Rec.Anlog | 329 | $318K |
| Insulin Pump Cart,automated,bt | 138 | $306K |
| Insulin Regular, Human | 104 | $303K |
| Dulaglutide | 176 | $286K |
| Insulin Degludec | 199 | $275K |
| Empagliflozin | 261 | $250K |
| Insulin Aspart | 157 | $234K |
| Finerenone | 200 | $198K |
| Insulin Lispro | 180 | $191K |
| Insulin Lispro | 92 | $124K |
| Evolocumab | 100 | $123K |
| Insulin Glargine,hum.Rec.Anlog | 129 | $100K |
Prescribing Profile
Patient Profile
68
Avg Age
64%
Female
1.66
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data